25 September 2023
Japan’s Ministry of Health, Labour and Welfare approves GSK’s Arexvy, the country’s first respiratory syncytial virus (RSV) vaccine for older adults · Arexvy’s approval will help protect…
25 September 2023 · Aviva to acquire AIG’s UK protection business for consideration of £460m · Supports Aviva’s strategy to grow capital-light businesses · Accelerates Aviva’s growth…
22 September 2023
22 September 2023 Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in…
21 September 2023
JD SPORTS FASHION PLC UNAUDITED INTERIM RESULTS FOR THE 26 WEEKS TO 29 JULY 2023 JD Sports Fashion Plc (the ‘Group’), the leading retailer…
NEXT PLC Results for the Half Year Ending July 2023 NEXT plc’s Half Year Report has been submitted in full unedited text to the…
Halma PLC 21 September 2023 Trading update Halma, the global group of life-saving technology companies focused on growing a safer, cleaner and healthier future,…
20 September 2023
20 September 2023 Alexion completes purchase and licence agreement for early-stage rare disease gene therapy portfolio from Pfizer Alexion, AstraZeneca Rare Disease, has completed…
20 September 2023 Interim Results for the six months ended 30 June 2023 Winsford, UK, 20 September 2023: Advanced Medical Solutions Group plc (AIM: AMS),…